Ljiljana Stamatović
Goethe University Frankfurt(DE)Heidelberg University(DE)University Hospital Heidelberg(DE)Oncology Institute of Vojvodina(RS)NSABP Foundation(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Global Cancer Incidence and Screening, Estrogen and related hormone effects
Most-Cited Works
- → Delays in diagnosis and treatment of breast cancer: a multinational analysis(2013)146 cited
- → Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer(2025)87 cited
- → Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study(2021)67 cited
- → Patient‐reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2–positive breast cancer(2020)24 cited
- → Factors influencing time to seeking medical advice and onset of treatment in women who are diagnosed with breast cancer in Serbia(2017)12 cited
- Polymorphic expression of glutathione transferases A1, M1, P1 and T1 in epithelial ovarian cancer: a Serbian case-control study.(2017)